Medical Science News

RSS
Sugar-binding pockets in N-terminal domain may increase SARS-CoV-2 infectivity

Sugar-binding pockets in N-terminal domain may increase SARS-CoV-2 infectivity

SARS-CoV-2 variants are evolving new ways to evade antibodies and vaccines

SARS-CoV-2 variants are evolving new ways to evade antibodies and vaccines

Study identifies several proteins that protect against disease development

Study identifies several proteins that protect against disease development

Study shows SARS-CoV-2 transmission in Ireland before first official COVID-19 report

Study shows SARS-CoV-2 transmission in Ireland before first official COVID-19 report

AlphaFold AI predicts SARS-CoV-2 omicron variant might not evade antibody neutralization

AlphaFold AI predicts SARS-CoV-2 omicron variant might not evade antibody neutralization

Characterization of the baseline SARS-CoV-2 S-reactive B cell repertoire

Characterization of the baseline SARS-CoV-2 S-reactive B cell repertoire

Interactions between RNA viruses and human RNA-binding proteins

Interactions between RNA viruses and human RNA-binding proteins

SARS-CoV-2 antibody profiles in vaccinated and convalescent macaques compared to humans

SARS-CoV-2 antibody profiles in vaccinated and convalescent macaques compared to humans

Equilibrium simulation of SARS-CoV-2 spike protein highlights its global conformational characteristics

Equilibrium simulation of SARS-CoV-2 spike protein highlights its global conformational characteristics

Breastmilk T cell repertoire is enriched for SARS-CoV-2 Spike-specificity after maternal mRNA vaccination

Breastmilk T cell repertoire is enriched for SARS-CoV-2 Spike-specificity after maternal mRNA vaccination

Impact of COVID-19 on children with complex underlying medical conditions

Impact of COVID-19 on children with complex underlying medical conditions

Optimizing the treatment of epilepsy patients

Optimizing the treatment of epilepsy patients

Estimating transmission heterogeneity dynamics of SARS-CoV-2 in Massachusetts

Estimating transmission heterogeneity dynamics of SARS-CoV-2 in Massachusetts

Brain injury markers associated with dysregulated immunological responses in COVID-19

Brain injury markers associated with dysregulated immunological responses in COVID-19

Quantum mechanical characterization of SARS-CoV-2 Omicron variant interaction with human ACE2 receptor

Quantum mechanical characterization of SARS-CoV-2 Omicron variant interaction with human ACE2 receptor

Computational comparison of SARS-CoV-2 Delta and Omicron variant binding affinity with ACE2

Computational comparison of SARS-CoV-2 Delta and Omicron variant binding affinity with ACE2

Does a COVID-19 vaccine booster improve the immune response of a poor responder?

Does a COVID-19 vaccine booster improve the immune response of a poor responder?

Epigenetic clocks have potential as biomarkers of COVID-19 vaccine responses

Epigenetic clocks have potential as biomarkers of COVID-19 vaccine responses

ORF10 protein mutations alter SARS-CoV-2 pathogenicity

ORF10 protein mutations alter SARS-CoV-2 pathogenicity

The antiviral potential of 4′-fluorouridine as an oral treatment against RSV and SARS-CoV-2

The antiviral potential of 4′-fluorouridine as an oral treatment against RSV and SARS-CoV-2

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.